Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quercetin and Related Analogs as Therapeutics to Promote Tissue Repair. | Bioengineering (Basel) | 2023 | 37892857 | PubTator, text mining | PubMed |
| Navigating the ERK1/2 MAPK Cascade. | Biomolecules | 2023 | 37892237 | PubTator, text mining | PubMed |
| Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma. | Commun Med (Lond) | 2023 | 37880538 | PubTator, text mining | PubMed |
| Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas. | Cancer Sci | 2023 | 37840379 | PubTator, text mining | PubMed |
| Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding. | Int J Mol Sci | 2023 | 37834301 | PubTator, text mining | PubMed |
| p90RSK2, a new MLCK mediates contractility in myosin light chain kinase null smooth muscle. | Front Physiol | 2023 | 37781225 | PubTator, text mining | PubMed |
| Establishment of linkage phase, using Oxford Nanopore Technologies, for preimplantation genetic testing of Coffin-Lowry syndrome with a de novo RPS6KA3 mutation. | Front Genet | 2023 | 37779904 | PubTator, text mining | PubMed |
| Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study. | Anticancer Res | 2023 | 37772577 | PubTator, text mining | PubMed |
| Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence. | Int J Mol Sci | 2023 | 37762556 | PubTator, text mining | PubMed |
| Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time? | Int J Mol Sci | 2023 | 37762533 | PubTator, text mining | PubMed |
| Advances in Histological and Molecular Classification of Hepatocellular Carcinoma. | Biomedicines | 2023 | 37761023 | PubTator, text mining | PubMed |
| FGFR families: biological functions and therapeutic interventions in tumors. | MedComm (2020) | 2023 | 37750089 | PubTator, text mining | PubMed |
| Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer. | Medicine (Baltimore) | 2023 | 37747033 | PubTator, text mining | PubMed |
| Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. | Cell Adh Migr | 2023 | 37726886 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
| Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. | Nat Commun | 2023 | 37704624 | PubTator, text mining | PubMed |
| Therapeutic Promises of Plant Metabolites against Monkeypox Virus: An In Silico Study. | Adv Virol | 2023 | 37693295 | PubTator, text mining | PubMed |
| A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers. | Int J Mol Sci | 2023 | 37686122 | PubTator, text mining | PubMed |
| CRISPR applications in cancer diagnosis and treatment. | Cell Mol Biol Lett | 2023 | 37674114 | PubTator, text mining | PubMed |
| SEC23A confers ER stress resistance in gastric cancer by forming the ER stress-SEC23A-autophagy negative feedback loop. | J Exp Clin Cancer Res | 2023 | 37670384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=6